Extra-Ordinary General Meeting of the our Company will be held on Wednesday, 7th Jnauary, 2026 at 04:00 P.M. through VC/OAVM to transact the businesses as set out in the Notice of EGM attached ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hemo Organic Limited has called an EGM on 7th January 2026 (via video conference) to seek shareholder approval for two key items. First, to increase the authorised share capital from Rs. 10 crore (1 crore equity shares of Rs. 10 each) to Rs. 13.45 crore (1.345 crore equity shares of Rs. 10 each), along with a corresponding amendment to the Memorandum of Association. Second, to issue up to 99,75,000 convertible warrants at Rs. 12.50 each (including Rs. 2.50 premium) on a preferential basis to three Non-Promoter allottees, aggregating to Rs. 12.47 crore. The allottees are Vishwambar Kameshwar Singh (Managing Director) for 33,00,000 warrants, Vacro Enterprises Private Limited for 33,50,000 warrants, and Qmin Realities Private Limited for 33,25,000 warrants. The company plans to use the proceeds mainly for working capital (Rs. 9.35 crore) and general corporate purposes (Rs. 3.12 crore). Warrants must be converted within 18 months, with 25% payable upfront.
If approved, existing shareholders face significant potential dilution as 99.75 lakh new shares could be issued on conversion, against the current 1 crore authorised base. The capital raise should strengthen working capital, but minority shareholders should note the heavy concentration of warrants to three allottees, including the Managing Director himself (categorised as Non-Promoter), and watch for stock price pressure around the EGM and conversion events.